KEGG   DRUG: Insulin injection, biphasic isophane
Entry
D08080                      Drug                                   
Name
Insulin injection, biphasic isophane (BAN);
Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension (JP18);
Insulin Humacart (TN)
Class
Antidiabetic agent
 DG01636  Insulin preparation
  DG01802  Human insulin
Metabolizing enzyme inducer
 DG01637  CYP1A2 inducer
Remark
Product: D08080<JP>
Efficacy
Antidiabetic, Insulin receptor agonist
Comment
Insulin with both rapid and intermediate action
Target
INSR (CD220) [HSA:3643] [KO:K04527]
  Pathway
hsa04910  Insulin signaling pathway
Interaction
CYP induction: CYP1A2 [HSA:1544]
Brite
Drug groups [BR:br08330]
 Antidiabetic agent
  DG01636  Insulin preparation
   DG01802  Human insulin
    D08080  Insulin injection, biphasic isophane
 Metabolizing enzyme inducer
  DG01637  CYP1A2 inducer
   D08080  Insulin injection, biphasic isophane
Drug classes [BR:br08332]
 Antidiabetic agent
  DG01636  Insulin preparation
   D08080  Insulin injection, biphasic isophane
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   INSR family
    INSR (CD220)
     D08080  Insulin injection, biphasic isophane (BAN) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D08080  Biphasic isophane insuline human (genetical recombination) injectable aqueous suspension
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D08080
Other DBs
CAS: 8063-29-4
PubChem: 96024770

» Japanese version   » Back

DBGET integrated database retrieval system